SaneVax, Inc.

Safe, Affordable, Necessary & Effective Vaccines and Vaccination Practices

Reduction in HPV Prevalence— No Evidence to Support HPV Vaccination reduces HPV Prevalence

By

Authors:  Jennifer A. Groner1, George D. Harris2 and Diane M. Harper3,4,5  TO THE EDITOR—The recent Centers for Disease Control and Prevention (CDC) study by Markowitz et al [1] provides limited and inconclusive data on 111 sexually active females between 14 and 19 years of age who received at least 1 dose of quadrivalent human papillomavirus vaccine (HPV4). The […]




[Continue reading...]

Review of Gardasil

By

Authors: Diane M Harper,1,* Stephen L. Vierthaler,2 and Jennifer A Santee3 Abstract Human papillomavirus (HPV) is necessary for the development of cervical cancer. Cervical cancer is the second most common cancer in women worldwide but 80% occurs in developing countries, not countries with Pap screening programs. Pap screening programs in industrialized countries have reduced the incidence […]




[Continue reading...]

Is Chronic Fatigue Syndrome/Myalgic Encephalomyelitis a Relevant Diagnosis in Patients with Suspected Side Effects to Human Papilloma Virus Vaccine?

By

Authors: Louise Brinth*, Kirsten Pors, Anna-Alexandra Grube Hoppe, Iman Badreldin and Jesper Mehlsen Frederiksberg Hospital, Denmark Abstract The quadrivalent human papilloma virus vaccine (Q-HPV-vaccine) was included into the Danish childhood vaccination program in 2009. During the past years possible side effects have been described in several countries encompassing a collection of symptoms consistent with pronounced […]




[Continue reading...]

Transmission of High-Risk Human Papillomavirus (HPV) between Parents and Infant: a Prospective Study of HPV in Families in Finland

By

Transmission of HPV Authors:  Marjut A. M. Rintala1,* Seija E Grénman1, Mirja H. Puranen2,3, Erika Isolauri4, Ulla Ekblad1, Pentti O. Kero4 and Stina M. Syrjänen2,3 ABSTRACT The Finnish HPV Family Study is a prospective cohort study assessing the dynamics of human papillomavirus (HPV) transmission between parents and infant. Serial genital and oral scrapings from 76 families, including mother, father, and infant, and […]




[Continue reading...]

Vaccination Persuasion Online: A Qualitative Study of Two Provaccine and Two Vaccine-Skeptical Websites

By

Authors: Lenny Grant, MA,MAT; Bernice L Hausman, PhD; Margaret Cashion, BS; Nicholas Lucchesi, BS; Kelsey Patel, BS; Jonathan Roberts, BA ABSTRACT Background: Current concerns about vaccination resistance often cite the Internet as a source of vaccine controversy. Most academic studies of vaccine resistance online use quantitative methods to describe misinformation on vaccine-skeptical websites. Findings from these […]




[Continue reading...]

Human papillomavirus (HPV) is not the main cause of preinvasive and invasive cervical cancer among patients in Delta Region, Egypt

By

Is 'protecting' against 4 types of HPV enough to warrant the risks?

Not the Main cause of Preinvasive and Invasive Cervical Cancer Authors: Thabet M, Hemida R, Hasan M, Elshamy M, Elfaraash M, Emam M. Abstract BACKGROUND: Cervical cancer remains a significant problem worldwide particularly in underdeveloped countries. It is necessary to have a persistent infection of the cervix with a high-risk or oncogenic human Papillomavirus (HPV) virus […]




[Continue reading...]

Etiology of autism spectrum disorders: Genes, environment, or both?

By

Authors: C Shaw, S Sheth, D Li, L Tomljenovic Abstract Introduction Thus far, most of the research on both neurodevelopmental and neurodegenerative disorders has been focused on finding the presumed underlying genetic causes, while much less emphasis has been put on potential environmental factors. While some forms of autism are clearly genetic, the fact remains that […]




[Continue reading...]

Hypothesis: Human papillomavirus vaccination syndrome—small fiber neuropathy and dysautonomia could be its underlying pathogenesis

By

By Martinez-Lavin, M Abstract Vaccination has been one of the most effective public health measures in the history of medicine. However, seemingly inexplicit adverse reactions have been described after the injection of the newer vaccines vs. human papillomavirus (HPV). The symptoms more often reported are chronic pain with paresthesias, headaches, fatigue, and orthostatic intolerance. Adverse […]




[Continue reading...]

Autoimmune/auto-inflammatory syndrome induced by adjuvants (ASIA) after quadrivalent human papillomavirus vaccination in Colombians: a call for personalised medicine

By

Authors: Anaya JM1, Reyes B1, Perdomo-Arciniegas AM2, Camacho-Rodríguez B2, Rojas-Villarraga A1 Abstract This was a case study in which 3 patients with autoimmune/auto-inflammatory syndrome induced by adjuvants (ASIA) after quadrivalent human papillomavirus vaccination (HPV) were evaluated and described. All the patients were women. Diagnosis consisted of HLA-B27 enthesitis related arthritis, rheumatoid arthritis and systemic lupus erythematous, […]

[Continue reading...]

Human Papillomavirus in Infants: Transmission, Prevalence, and Persistence

By

Is 'protecting' against 4 types of HPV enough to warrant the risks?

Author: Delese E. LaCour, MD* Introduction Infections caused by human papillomavirus (HPV) result in considerable morbidity and mortality throughout the world.1–4 Conditions such as anogenital warts, caused by low-risk HPV genotypes and cervical dysplasia, more commonly caused by oncogenic HPV types, can affect females in all age groups.5–9 The prevalence of low and high risk HPV […]




[Continue reading...]

HPV prevalence and risk of pre-cancer and cancer in regular immigrants in Italy: results from HPV DNA test-based screening pilot programs

By

Authors: Cinzia Campari12, Chiara Fedato3, Alessio Petrelli4, Manuel Zorzi5, Carla Cogo5, Adele Caprioglio6, Federica Gallo6, Livia Giordano6, Serena Domenighini7, Luigi Pasquale7, Sonia Prandi8, Marco Zappa9, Paolo Giorgi Rossi102* and the GISCi Migrant Working Group Abstractᅟ Immigrants from low- and medium-income countries have a higher risk of cervical cancer due both to barriers in access to screening […]

[Continue reading...]

Reduction in HPV prevalence?

By Leave a Comment

Is 'protecting' against 4 types of HPV enough to warrant the risks?

[SaneVax: Following is an excerpt from a letter to the editor of The Journal of Infectious Diseases that provides a critique of a scientific study used to demonstrate the success of HPV vaccination programs in the United States. Evidently, things are not so cut and dried as the CDC would like us to believe.] Reduction in HPV Prevalence—No […]




[Continue reading...]

Orthostatic intolerance and postural tachycardia syndrome as suspected adverse effects of vaccination against human papilloma virus

By Leave a Comment

Authors: Louise S. Brinth, Kirsten Pors, Ann C. Theibel, Jesper Mehlsen Abstract Background Infections with human papilloma virus (HPV) can result in cervical, oropharyngeal, anal, and penile cancer and vaccination programs have been launched in many countries as a preventive measure. We report the characteristics of a number of patients with a syndrome of orthostatic intolerance, headache, fatigue, cognitive […]




[Continue reading...]

Global availability of data on HPV genotype-distribution in cervical, vulvar and vaginal disease and genotype-specific prevalence and incidence of HPV infection in females

By Leave a Comment

Is 'protecting' against 4 types of HPV enough to warrant the risks?

Authors: Monika Wagner1*, Liga Bennetts1, Harshila Patel1, Sharon Welner1, Silvia de Sanjose34 andThomas W Weiss2 Abstract (provisional) Background Country-level HPV genotyping data may be sought by decision-makers to gauge the genotype-specific burden of HPV-related diseases in their jurisdiction and assess the potential impact of HPV vaccines. We investigated, by country, the availability of published literature on […]




[Continue reading...]

Preliminary development of treatment for HPV vaccine injured girls

By 2 Comments

By Stig Gerdes, MD Dear reader, Here is a preliminary statement of my diagnosis and treatment of 13 very, very sick women, of whom 11 are HPV vaccine injured and 2 are affected by ME (myalgic encephalomyelitis). As seen, the treatment has an effect and I have no doubt that it is curative in some […]




[Continue reading...]

Harm of HPV vaccines: Epidemiologic studies NEVER Show Safety

By 1 Comment

Published by Med Check: the Informed Prescriber, Japan Editor in Chief, Rokuro Hama, MD Chairperson of NPO Japan Institute of Pharmacovigilance; Deputy Editors, Deputy Editors, Y. Kimoto, MD and N Tanida, MD Plain Language summary: Two products of HPV vaccines (Cervarix and Gardasil) are marketed in Japan since 2010. More than 3 million girls were inoculated with […]




[Continue reading...]

Population-level impact and herd effects following human papillomavirus vaccination  programmes:

By Leave a Comment

a systematic review and meta-analysis Authors: Mélanie Drolet, PhD†, Élodie Bénard, BSc, Marie-Claude Boily, PhD, Hammad Ali, PhD, Louise Baandrup, MD, Heidi Bauer, MD, Simon Beddows, PhD, Jacques Brisson, DSc, Julia M L Brotherton, BMed, Teresa Cummings, BA, Basil Donovan, MD, Christopher K Fairley, PhD, Elaine W Flagg, PhD, Anne M Johnson, MD, Jessica A Kahn, MD, Kimberley Kavanagh, PhD, Susanne K Kjaer, MD, Erich V Kliewer, PhD, Philippe Lemieux-Mellouki, MSc, Lauri Markowitz, MD, Aminata Mboup, […]




[Continue reading...]

Cervical screening rates for women vaccinated against human papillomavirus

By Leave a Comment

Authors: Budd AC1, Brotherton JM2, Gertig DM2, Chau T3, Drennan KT2, Saville M2 Abstract OBJECTIVE: To compare cervical screening rates for women vaccinated with a quadrivalent human papillomavirus (HPV) vaccine with those for unvaccinated women, to address concerns that vaccinated women may not be participating in cervical screening. DESIGN, SETTING AND PARTICIPANTS: Cross-sectional analysis of […]




[Continue reading...]

Cytokine levels in cervical cancers: HPV 16/18 vs non HPV 16/18 genotypes

By Leave a Comment

IL-10, IL-15, IL-17, and GMCSF levels in cervical cancer tissue of Tanzanian women infected with HPV16/18 vs. non-HPV16/18 genotypes By Adriana C Vidal1, David Skaar2, Rachel Maguire2, Seyram Dodor3, Laura W Musselwhite4, John A Bartlett5, Olola Oneko6, Joseph Obure6, Pendo Mlay6, Susan K Murphy7 and Cathrine Hoyo2* Abstract Background Despite comparable screening rates for precancerous lesions, […]




[Continue reading...]

Human adjuvant-related syndrome or autoimmune/inflammatory syndrome induced by adjuvants

By Leave a Comment

Where have we come from? Where are we going? A proposal for new diagnostic criteria. By Alijotas-Reig J. Lupus. 2015. Abstract In 1964, Miyoshi reported a series of patients with diverse symptoms after receiving treatment with silicone or paraffin fillers. Miyoshi named this condition ‘human adjuvant disease’. Since then, the literature has been flooded with case […]




[Continue reading...]

News

Videos

Contact